Davide Mariotti

9PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Horticultural crop improvement (incl. selection and breeding)Innate immunityMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 07, 2025
Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive Therapies.

Mario Ferraioli, Alessandra Aiello, Immacolata Prevete

|May 07, 2025
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine.

Alessandra Vergori, Giulia Matusali, Eleonora Cimini

|Jul 27, 2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.

Alessandra Vergori, Giulia Matusali, Eleonora Cimini

|Dec 23, 2023
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV.

Alessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali

|Nov 17, 2022
Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells.

Giulio Bontempi, Michela Terri, Sabrina Garbo

|Sep 23, 2022
SARS-CoV-2 Infection of Airway Epithelium Triggers Pulmonary Endothelial Cell Activation and Senescence Associated with Type I IFN Production.

Veronica Bordoni, Davide Mariotti, Giulia Matusali

Pageof 2

Frequent Collaborators

4 joint publications

Fabrizio Maggi

4 joint publications

Alessandra Vergori

4 joint publications

Valentina Mazzotta

4 joint publications

Giulia Matusali